Shopping Cart
- Remove All
Your shopping cart is currently empty
B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $41 | In Stock | |
| 5 mg | $65 | In Stock | |
| 10 mg | $103 | In Stock | |
| 25 mg | $176 | In Stock | |
| 50 mg | $251 | In Stock | |
| 100 mg | $363 | In Stock | |
| 200 mg | $483 | In Stock |
| Description | B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease |
| Synonyms | Linazolamide intermediate B impurity 2, CPNQ, 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline |
| Molecular Weight | 396.83 |
| Formula | C20H17ClN4O3 |
| Cas No. | 115687-05-3 |
| Smiles | [O-][N+](=O)c1ccc(N2CCN(CC2)C(=O)c2ccc(Cl)cc2)c2cccnc12 |
| Relative Density. | 1.412 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 2 mg/mL (5.04 mM), Sonication is recommended. DMSO: 50 mg/mL (126 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.